Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? - Test2 - elhamkhani - TriplyDB

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

http://www.wikidata.org/entity/Q33670134

about

Designing the next generation of medicines for malaria control and eradication New developments in anti-malarial target candidate and product profiles Cost analysis of school-based intermittent screening and treatment of malaria in Kenya A qualitative review of implementer perceptions of the national community-level malaria surveillance system in Southern Province, Zambia.Pill characterization data streams for reducing exposure to inadequately identified anti-malarial medication in developing countries.Longitudinal study on Plasmodium falciparum gametocyte carriage following artemether-lumefantrine administration in a cohort of children aged 12-47 months living in Western Kenya, a high transmission area Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether-Lumefantrine: Impact on the Prevalence of Anemia.Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workers Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study PCR-based pooling of dried blood spots for detection of malaria parasites: optimization and application to a cohort of Ugandan children Dynamics of malaria transmission and susceptibility to clinical malaria episodes following treatment of Plasmodium falciparum asymptomatic carriers: results of a cluster-randomized study of community-wide screening and treatment, and a parallel ento Evaluation of the loop mediated isothermal DNA amplification (LAMP) kit for malaria diagnosis in P. vivax endemic settings of Colombia The relationship between Plasmodium infection, anaemia and nutritional status in asymptomatic children aged under five years living in stable transmission zones in Kinshasa, Democratic Republic of Congo.Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design.Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia.The usefulness of school-based syndromic surveillance for detecting malaria epidemics: experiences from a pilot project in Ethiopia The complexities of malaria disease manifestations with a focus on asymptomatic malaria Diagnosis of Malaria Infection with or without Disease.Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya.Prevalence of asymptomatic malaria infection and use of different malaria control measures among primary school children in Morogoro Municipality, Tanzania High Prevalence of Plasmodium falciparum Infection in Asymptomatic Individuals from the Democratic Republic of the Congo.A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso.Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda.Battling Malaria in Rural Zambia with Modern Technology: A Qualitative Study on the Value of Cell Phones, Geographical Information Systems, Asymptomatic Carriers and Rapid Diagnostic Tests to Identify, Treat and Control Malaria.Malaria elimination: surveillance and response.Submicroscopic malaria parasite carriage: how reproducible are polymerase chain reaction-based methods?Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.Detection of intracellular parasites by use of the CellaVision DM96 analyzer during routine screening of peripheral blood smears.The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.Coartem(®): a decade of patient-centric malaria management.A novel, sensitive assay for high-throughput molecular detection of plasmodia for active screening of malaria for elimination.Sensitive detection and accurate monitoring of Plasmodium vivax parasites on routine complete blood count using automatic blood cell analyzer (DxH800(TM)).Age-specific Plasmodium parasite profile in pre and post ITN intervention period at a highland site in western Kenya.Comparison of asymptomatic Plasmodium spp. infection in two malaria-endemic Colombian locations.Negligible Impact of Mass Screening and Treatment on Meso-endemic Malaria Transmission at West Timor in Eastern Indonesia: A Cluster-Randomised Trial

P2860

Q26859195-D4A38FED-6D27-4887-AD72-74F84B5178AD Q28468598-C5ADBAB6-C9BA-4D59-8DA1-EDA83B373191 Q28744234-9CBF1C39-CAB9-4EA5-A8B2-70475BC39B7B Q30248575-71CCFD85-5233-4BB4-BE3D-7A2B0BEE730E Q33637883-79876314-3FC6-4AB7-9F9F-DEF293E36B4D Q33928116-D0654C35-7065-4497-9543-7300D6D68CE6 Q33939028-EE38E5CA-D17D-458F-8990-A16D2BF16F72 Q33960088-17482294-1D7C-40F2-B887-D3A0EEA46035 Q34154816-CE19FBD6-1C41-4947-BF33-4897EE37878D Q34190509-F268FF91-D93F-4B0C-AACA-D5221C74BF30 Q34478989-8F27992F-9352-4811-B627-FC4512EAB1D9 Q34875343-7341AC4F-290E-497E-A4DA-006AC0606202 Q35108578-682A1E3B-DAB3-4CA8-9D56-ACC364AEA267 Q35179184-377019D6-0098-4D1A-B704-3D95FA236099 Q35198733-56BC5B8D-7722-465F-8334-3DC246507B1F Q35590734-4E1B1A4F-A765-4F9A-BFA3-90AFA410371D Q35737774-7E5C0ED4-BD63-475D-8E87-678E881B776B Q35889640-73B13D44-166B-4ADC-81D5-67AC39607FF8 Q35930447-01888145-C359-442A-A519-842F420A77FC Q36033947-A93A6057-2242-4B61-9A71-071662322001 Q36173400-6779059C-0A20-42C1-B67F-0ADA865F1E20 Q36344214-AD4D9D74-5914-49A9-B549-B5835AB7A215 Q36569073-23CFDEFC-6DBE-44D0-BC9C-DFDA5F81B23F Q36690099-164C0C48-61FB-44E5-A20D-8E0C419896A5 Q36931785-B989B76B-5B8A-4524-89C0-123AA217A618 Q37693068-1531BE65-C2E9-4AF6-A005-DE576C5E1ED2 Q37726763-8CCA1861-4B0A-4A17-AD1E-8E5D3BDFA16B Q37734108-AB20B1A9-4165-4CF2-9033-50448306E219 Q37857327-B3A4B994-E155-4172-BC54-99900E9CAE93 Q38266006-BA69F414-935D-4CA8-88D2-99501D0F4EBC Q38840716-E6070CAE-DD92-474E-A83F-37AF96723AAD Q39042892-FE750F4C-75C5-4A74-A218-CE4B68770FE9 Q42288946-30581D58-217A-4838-A77B-928EA73979D0 Q43536648-6C1AB46E-3E27-4BB8-BC2B-C17D961598A6 Q46121031-BAAC673D-CBDE-43EF-BEFC-225D22EA3BF0 Q46830597-A999DB2F-8FB8-4E21-B5A0-E08DA0F291EC Q56366334-50F34687-749F-42B6-957F-0D2D76D33910

P2860

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

http://www.wikidata.org/entity/Q33670134

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Treatment of asymptomatic carr ...... reduce the burden of malaria?

@ast

Treatment of asymptomatic carr ...... reduce the burden of malaria?

@en

type

label

Treatment of asymptomatic carr ...... reduce the burden of malaria?

@ast

Treatment of asymptomatic carr ...... reduce the burden of malaria?

@en

prefLabel

Treatment of asymptomatic carr ...... reduce the burden of malaria?

@ast

Treatment of asymptomatic carr ...... reduce the burden of malaria?

@en

P1433

Q33670134-E366298D-B89C-4A35-9747-5C8F7C671BBD

P1476

Q33670134-531E9EDD-B1CF-41B7-86C1-6FAEBD018EA6

P2093

Q33670134-0151C989-C275-47CA-8FDB-E23571E6DF3C

Q33670134-24E4A00D-8151-409E-BF5F-68F885680420

Q33670134-669DA3FC-E3A8-47B8-9C7B-5A53355BA8E6

Q33670134-75259889-7B53-4BC5-9B2D-F4DA78EE1F56

Q33670134-8A324220-2C9B-46BE-8AE7-ECFED91D5A20

Q33670134-EDF27B36-CF05-4775-ACDC-8353AD9BC623

P2860

Q33670134-0E483CAD-1068-4F31-A744-68AE45B14C4C

Q33670134-11F1CBAD-55C0-47A3-94D9-66DB4442C11E

Q33670134-1D40F87A-1ED3-40CD-93E9-C82CCFCA1616

Q33670134-1E0198DD-7DFD-48EB-91DF-B2F2CED88621

Q33670134-20D164FE-75D4-4F63-889C-918BB70DE2B5

Q33670134-2543CCBA-586F-4379-8A07-398F974EE159

Q33670134-2C9C7D07-BE2F-4F42-8D9E-8CADEE2839A6

Q33670134-2D7D3EBF-FECB-49E5-8A81-B941B492574A

Q33670134-2EE4D4B4-B029-4E41-8DFB-1A172A65EA5A

Q33670134-2F5CA6BC-681B-49D1-A3B2-560B7120C49D

P2888

Q33670134-9CF6D044-6B37-4A0E-8CE5-5ECDCE6D718F

P304

Q33670134-4825F4A8-8AC2-4D07-B22D-EAAC3CCC9D20

P31

Q33670134-399df107-f920-4ef9-9717-2b36333542ac

Q33670134-E7EDAEC2-C7AF-4B26-AE3C-2411E4EEAC69

P356

Q33670134-9DD14815-6098-4C21-B37A-50FDFEFBB598

P478

Q33670134-E5E608B7-F23D-4EE6-8E52-16B8DBCE9054

P50

Q33670134-9B47FCD4-2A3E-402A-9CE2-E113B2B5FDE6

Q33670134-DA988495-2068-4B40-9FBD-B88CD7D2478C

P577

Q33670134-E4185948-B170-46CF-8E42-D0C63C176DE8

P5875

Q33670134-C0F09A4C-A966-4731-BAA3-6A3E171C8B54

P6179

Q33670134-7A94A15D-F3F4-434F-9591-CEEC4B69450E

P698

Q33670134-B8FC96D1-A388-4FF5-B7EE-4077DBAD7C1F

P921

Q33670134-59C739A4-DA49-4B3D-94F0-A96748C9BFED

P932

Q33670134-9AEC9004-981D-422B-B1A9-46F33B54164B

P356

P1433

Malaria Journal

P1476

Treatment of asymptomatic carr ...... reduce the burden of malaria?

@en

P2093

Adama Dodji Gbadoé

http://www.w3.org/2001/XMLSchema#string

Alfred B Tiono

http://www.w3.org/2001/XMLSchema#string

Anne Claire Marrast

http://www.w3.org/2001/XMLSchema#string

David Ubben

http://www.w3.org/2001/XMLSchema#string

Oumar Gaye

http://www.w3.org/2001/XMLSchema#string

Zulfiqarali Premji

http://www.w3.org/2001/XMLSchema#string

P2860

The economic and social burden of malaria

Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar

The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.

Anemia and iron deficiency: effects on pregnancy outcome.

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.

P2888

P304

30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-9-30

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Bernhards Ogutu

Michael Makanga

P577

2010-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41121501

http://www.w3.org/2001/XMLSchema#string

P6179

1027550312

http://www.w3.org/2001/XMLSchema#string

P698

20096111

http://www.w3.org/2001/XMLSchema#string

P921

P932

2824802

http://www.w3.org/2001/XMLSchema#string